COMPANY
Clinical Phase 1
Keywords: antibody Neoplasm Malignant Experimental Neoplasm Lymphoma AWT020
Location: San Carlos, CA · source · Oct 12, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: A Study of AWT020 in Participants With Advanced Solid Tumors source ↗
- Trial start 1: Phase 1 Study of AWT020 in Advanced Cancer source ↗
- Trial start 1: Phase 1 First-in-human Study of JS014 source ↗
Upcoming milestones
- 2029-01 (ESTIMATED) · Phase 1 · A Study of AWT020 in Participants With Advanced Solid Tumors · NCT07822919
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07822919 | A Study of AWT020 in Participants With Advanced Solid Tumors | Phase 1 | Recruiting | Sep 11, 2026 | 2029-01 (estimated) |
| NCT06092580 | Phase 1 Study of AWT020 in Advanced Cancer | 1 | Recruiting | Sep 15, 2023 | Jun 30, 2026 (estimated) |
| NCT05296772 | Phase 1 First-in-human Study of JS014 | 1 | Unknown status (ClinicalTrials.gov) | Feb 28, 2022 | 2024-06 (estimated) |
